Thelansis

  Hypertriglyceridemia is a prevalent metabolic disorder characterized by elevated levels of triglycerides, a type of fat, in the bloodstream. It is a triglyceride concentration greater than 150 mg/dL in the blood. This condition has been linked to various diseases, including atherosclerosis, obesity, and insulin resistance, increasing the risk of cardiovascular disease (CVD). Severe hypertriglyceridemia (sHTG), defined as fasting triglyceride concentrations above 10.0 mmol/L, can be classified into two categories: 1. Polygenic hypertriglyceridemia (also known as type V hyperlipoproteinemia according to the Fredrickson classification) is caused by a combination of genetic, demographic, and clinical factors, including obesity, diabetes mellitus, untreated hypothyroidism, alcohol consumption, and certain medications. 2. Familial chylomicronemia syndrome (also known as type I hyperlipoproteinemia, according to the Fredrickson classification) is a genetic disorder. Both forms are ass...

Hypertriglyceridemia is a prevalent metabolic disorder characterized by elevated levels of triglycerides, a type of fat, in the bloodstream. It is a triglyceride concentration greater than 150 mg/dL in the blood. This condition has been linked to various diseases, including atherosclerosis, obesity, and insulin resistance, increasing the risk of cardiovascular disease (CVD). Severe hypertriglyceridemia (sHTG), defined as fasting triglyceride concentrations above 10.0 mmol/L, can be classified into two categories: 1. Polygenic hypertriglyceridemia (also known as type V hyperlipoproteinemia according to the Fredrickson classification) is caused by a combination of genetic, demographic, and clinical factors, including obesity, diabetes mellitus, untreated hypothyroidism, alcohol consumption, and certain medications. 2. Familial chylomicronemia syndrome (also known as type I hyperlipoproteinemia, according to the Fredrickson classification) is a genetic disorder. Both forms are associated ...